San Diego, CA - September 17, 2015 - Objective Capital Partners, a leading middle market investment bank focused on transactions for privately held companies with enterprise values up to $250 million, is pleased to announce that it has added Dr. David Crean as a Managing Director to lead its life sciences investment banking practice.
(more…)Insights
This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.
